Evaluation of the safety and efficacy of NE3107, a safe, orally bioavailable, blood-brain barrier-permeable anti-inflammatory and insulin-sensitizing agent for treatment of long covid
Active Project Grant Awarded Last action
- Award ID
- HT94252410113
- Recipient
-
Biovie Inc. UEI WF5HU3FN79L5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $499,200
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 81% complete
- Originally
- Place of performance
- Carson City, NV 89703, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $499,200 |
Quick answers
Who received award HT94252410113?
HT94252410113 was awarded to Biovie Inc. by Defense Health Agency (Department of Defense) on May 1, 2024.
How much is award HT94252410113 worth?
$499,200 has been obligated on HT94252410113.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award